Angiotensin II increases angiogenesis by NF‐κB–mediated transcriptional activation of angiogenic factor AGGF1

Abstract

Angiogenic factor with G-patch and FHA domains 1 (AGGF1) is involved in vascular development, angiogenesis, specification of hemangioblasts, and differentiation of veins. When mutated, however, it causes Klippel-Trenaunay syndrome, a vascular disorder. In this study, we show that angiotensin II (AngII)-the major effector of the renin-angiotensin system and one of the most important regulators of the cardiovascular system-induces the expression of AGGF1 through NF-κB, and that AGGF1 plays a key role in AngII-induced angiogenesis. AngII significantly up-regulated the levels of AGGF1 mRNA and protein in HUVECs at concentrations of 10-40 μg/ml but not >60 μg/ml. AngII type 1 receptor (AT1R) inhibitor losartan inhibited AngII-induced up-regulation of AGGF1, whereas AT2R inhibitor PD123319 further increased AngII-induced up-regulation of AGGF1. Up-regulation of AGGF1 by AngII was blocked by NF-κB inhibitors, and p65 binds directly to a binding site at the promoter/regulatory region of AGGF1 and transcriptionally activates AGGF1 expression. AngII-induced endothelial tube formation was blocked by small interfering RNAs (siRNAs) for RELA (RELA proto-oncogene, NF-κB subunit)/p65 or AGGF1, and the effect of RELA siRNA was rescued by AGGF1. AngII-induced angiogenesis from aortic rings was severely impaired in Aggf1 mice, and the effect was restored by AGGF1. These data suggest that AngII acts as a critical regulator of AGGF1 expression through NF-κB, and that AGGF1 plays a key role in AngII-induced angiogenesis.-Si, W., Xie, W., Deng, W., Xiao, Y., Karnik, S. S., Xu, C., Chen, Q., Wang, Q. K. Angiotensin II increases angiogenesis by NF-κB-mediated transcriptional activation of angiogenic factor AGGF1.

<p>Loxoprofen Sodium Alleviates Oxidative Stress and Apoptosis Induced by Angiotensin II in Human Umbilical Vein Endothelial Cells (HUVECs)</p>

“…24 In addition, the synthesis of NF-κB can be promoted by angiotensin II, which is a transcriptional factor that up-regulates the expression of adherence factors, inflammatory factors, epoxidase-2, and angiotensinogen. 25,26 It is reported that Angiotensin II-induced mitochondrial dysfunction reduces endothelial NO bioavailability and promotes ROS generation, 27 therefore Angiotensin II-impaired mitochondrial function could be one of the mechanisms of endothelial dysfunction. Besides, the renin-angiotensin system (RAS) can be activated by angiotensin II to inhibit the function of progenitor cells, which has been reported to be beneficial to the recovery of VEC function and alleviates the symptoms of arterial stiffness.…”

Thymosin‑β�4 induces angiogenesis in critical limb ischemia mice via regulating Notch/NF‑κB pathway

“…Previous studies have reported that Notch/NF-κB signaling pathway is highly related to the process of angiogenesis (36)(37)(38)(39)(40). Notch1 is part of the Notch family that regulates cell fate and VEGF expression in various types of cell, including HUVEC (10,39,41).…”

Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5‐cryab‐hspb2 signalling in zebrafish

“…We also co‐transfected 100 ng of either pMIR‐ cryab or pMIR‐ hspb2 together with si‐TBX5 or si‐NC as well as 20 ng of the pRL‐TK vector containing the renilla luciferase gene. Forty‐eight hours after transfection, cells were harvested, and used for luciferase assays using the Dual Luciferase Reporter Assay System (Promega) as described by us previously 35 . Luciferase activities were normalized to Renilla luciferase activity.…”